Skip to main content

HOME
About Us
Technology
Pipeline
News & Events
Contact

Topas Therapeutics GmbH

Falkenried 88, Haus A
20251 Hamburg GERMANY

+49 40 302089010
info@topas-therapeutics.com

CONTACT

CONTACT

CONTACT

HOME
About Us
Technology
Pipeline
News & Events
Contact

BioCentury Grand Rounds Europe

Written by Trophic Communications on 4. July 2025. Posted in Events.

BioCentury Grand Rounds Europe

Previous

Search

Recent Posts

BioCentury Grand Rounds Europe
Topas Therapeutics’ TPM502 Achieves Gluten-specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients
Topas Therapeutics Announces Presentation of Phase 2a Data for TPM502 in Celiac Disease at Digestive Disease Week® 2025 in San Diego
Topas Therapeutics Publishes Foundational Data Demonstrating Tolerance Induction by its Proprietary Nanoparticle Platform in Frontiers in Immunology
Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease

Recent Comments

No comments to show.

Privacy Policy
Imprint
info@topas-therapeutics.com

©2024 Topas Therapeutics. All rights reserved.